Article Details

In acute MI, dapagliflozin confers cardiometabolic benefit, in absence of diabetes, HF

Retrieved on: 2023-11-11 20:05:15

Tags for this article:

Click the tags to see associated articles and topics

In acute MI, dapagliflozin confers cardiometabolic benefit, in absence of diabetes, HF. View article details on HISWAI: https://www.healio.com/news/cardiology/20231111/in-acute-mi-dapagliflozin-confers-cardiometabolic-benefit-in-absence-of-diabetes-hf

Excerpt

... of treatment once-daily dapagliflozin (Farxiga, AstraZeneca) on a composite outcome of CV death or hospitalization for HF compared with placebo.

Article found on: www.healio.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up